Anxiolytics like benzodiazepines modulate GABA-A receptor activity, enhancing inhibitory neurotransmission and reducing neural hyperexcitability associated with Visual Snow Syndrome. By promoting central nervous system inhibition, these medications can potentially mitigate sensory processing abnormalities and reduce the intensity of visual disturbances while providing anxiolytic and mild sedative effects.